Federal Register / Vol. 65, No. 81 / Wednesday, April 26, 2000 / Notices 24493

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Neurological

Disorders and Stroke; Notice of Closed

Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5,

U.S.C., as amended. The grant

applications and the discussions could

disclose confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning individuals associated with

the grant applications, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Name of Committee: Training Grant and

Career Development Review Committee.

Date: June 9, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: One Washington Circle Hotel,

Conference Center, One Washington Circle,

Washington, DC 20037.

Contact Person: Lillian M. Pubols, Chief,

Scientific Review Branch, NINDS/NIH/

DHHS, Neuroscience Center, 6001 Executive

Blvd., Suite 3208, MSC 9529, Bethesda, MD

20892–9529, 301–496–9223, ip28e@nih.gov.

Name of Committee: National Institute of

Neurological Disorders and Stroke Initial

Review Group Neurological Sciences and

Disorders A

Date: June 22–23, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Katherine M. Woodbury,

Scientific Review Administrator, NINDS/

NIH/DHHS, National Institutes of Health,

Neuroscience Center, 6001 Executive Blvd.,

Suite 3208, MSC 9529, Bethesda, MD 20892–

9529, 301–496–9223.

Name of Committee: National Institute of

Neurological Disorders and Stroke Initial

Review Group Neurological Sciences and

Disorders B.

Date: June 22–23, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Radisson Barcelo Hotel, 2121 P St.,

NW, Washington, DC 20037.

Contact Person: Paul A. Sheehy, Scientific

Review Administrator, Scientific Review

Branch, NINDS/NIH/DHHS, Neuroscience

Center, 6001 Executive Blvd., Suite 3208,

MSC 9529, Bethesda, MD 20892–9529, 301–

496–9223.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.853, Clinical Research

Related to Neurological Disorders; 93.854,

Biological Basis Research in the

Neurosciences, National Institutes of Health,

HHS)

Dated: April 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10410 Filed 4–25–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

National Advisory Council on Drug

Abuse.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Advisory

Council on Drug Abuse.

Date: May 16–17, 2000.

Open: May 16, 2000, 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892.

Open: May 17, 2000, 9 a.m. to 11:30 a.m.

Agenda: This portion of the meeting will

be open to the public for announcements and

reports of administrative, legislative and

program developments in the drug abuse

field.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892.

Contact Person: Teresa Levitin, Director,

Office of Extramural Affairs, National

Institute on Drug Abuse, National Institutes

of Health, DHHS, Bethesda, MD 20892–9547,

(301) 443–2755.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: April 20, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10412 Filed 4–25–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 28, 2000.

Time: 3 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Michael Micklin,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3178,

MSC 7848, Bethesda, MD 20892, (301) 435–

1258, micklinm@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 4, 2000.

Time: 10 a.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

24494 Federal Register / Vol. 65, No. 81 / Wednesday, April 26, 2000 / Notices

Contact Person: Jean Hickman, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 4194, MSC 7808,

Bethesda, MD 20892, (301) 435–1146.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 4, 2000.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Jo Pelham, BA, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 4106, MSC 7814,

Bethesda, MD 20892, (301) 435–1786.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 5, 2000.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Calbert A. Laing, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 4210, MSC 7812,

Bethesda, MD 20892, 301–435–1221,

laingc@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 8, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hilton National Airport Hotel, 2399

Jefferson Davis Highway, Arlington, VA

22202.

Contact Person: Arnold Revzin, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 4192, MSC 7806,

Bethesda, MD 20892, (301) 435–1153.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 8, 2000.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Jo Pelham, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 4106, MSC 7814,

Bethesda, MD 20892, (301) 435–1786.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844, 93–

846–93.878, 93–892, 93–893, National

Institutes of Health, HHS)

Dated: April 18, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–10402 Filed 4–25–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 27, 2000.

Time: 9 a.m. to 11 a.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Michael Micklin,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3178,

MSC 7848, Bethesda, MD 20892, (301) 435–

1258, micklinm@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 2, 2000.

Time: 2:30 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Michael Micklin,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3178,

MSC 7848, Bethesda, MD 20892, (301) 435–

1258, micklinm@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 4, 2000.

Time: 10 a.m. to 1:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Michael Micklin,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3178,

MSC 7848, Bethesda, MD 20892, (301) 435–

1258, micklinm@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 9, 2000.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Marcelina B. Powers,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4152,

MSC 7804, Bethesda, MD 20892, (301) 435–

1720.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel, IFCN–8 (03).

Date: May 10, 2000.

Time: 8 a.m. to 10 a.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Samuel Rawlings,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5160,

MSC 7844, Bethesda, MD 20892, (301) 435–

1243.

Name of Committee: Center for Scientific

Review Special Emphasis Panel, VISB (01).

Date: May 10, 2000.

Time: 2 p.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Leonard Jakubczak,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5172,

MSC 7844, Bethesda, MD 20892, (301) 435–

1247.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)